Biological Clock in Cancer Cells Influences Tumor Growth

Most of the cells in the human body have an internal clock that sets a rhythm for the activities of our organs according to the time of the day. Cancer cells, however, often have a non-functioning or malfunctioning clock. Does the biological clock in cancer cells influence tumor growth? Yes, according to a study conducted by Nicolas Cermakian, a professor in McGill University's Department of Psychiatry.

Published in the journal BMC Biology, these results show for the first time that directly targeting the biological clock in a cancerous tumor has an impact on its development.

"There were indications suggesting that the malfunctioning clock contributed to rapid tumor growth, but this had never been demonstrated. Thanks to the use of a chemical or a thermic treatment, we succeeded in 'repairing' these cells' clock and restoring it to its normal functioning. In these conditions, tumor growth drops nearly in half", explains Cermakian, who is also Director of the Laboratory of Molecular Chronobiology at the Douglas Mental Health University Institute, one of the research centers of the CIUSSS de l'Ouest-de-l'Île-de-Montréal.

Although this preclinical demonstration was done on mice, this important discovery provides a glimpse of potential new ways to treat cancer in humans.

"Activating the biological clock in tumors could become an innovative approach in slowing their growth or that of metastases. This would give people more time to use more conventional treatment modalities, such as surgery or chemotherapy", says Cermakian. "It now remains to be shown that we can target the clocks in human tumors the same way."

For this study, Silke Kiessling, a postdoctoral fellow on Nicolas Cermakian's team, successfully adjusted the gears of the internal clocks in two types of cancer cells - skin and colon - to make them function properly. This repair, which was tested in mice and tissue cultures, slowed cancerous tumor growth. After about a week, the tumor treated in this manner was two-thirds smaller than the control tumor.

While it is difficult to say at this point what types of cancer might be amenable to such an approach, this new concept could lead to an improvement in human cancer treatment in the long term, the researchers say.

Source-Eurekalert